This event has CPD accreditation and an open oral and poster session. Abstracts can be submitted on any subject related to Bacteriophages
Abstracts for poster presentation only can be submitted up to two weeks before the event
You can download the instructions for authors at
www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
European Implementation of Bacteriophage Therapy: Impact of Medicinal Product Legislation on Tailored Hospital Care
Gilbert Verbeken, Queen Astrid Military Hospital, Burn Wound Centre, Brussels, Belgium
Regulation of replication of Shiga toxin-converting bacteriophages
Professor Grzegorz Wegrzyn, Department of Molecular Biology, University of Gdansk, Poland
Bacteriophages for healthy living
Dr Alexander Sulakvelidze, Intralytix, Inc, Baltimore, USA
Phage recombination
Dr Gary Sharples, Fellow of the Wolfson Research Institute for Health and Wellbeing, Visiting Senior Lecturer in the Department of Chemistry, Senior Lecturer in the School of Biological and Biomedical Sciences, Durham University, UK
Talk title to be confirmed
Professor. Dr. Martin J. Loessner, ETH Zurich, Institute of Food, Nutrition and Health, Schmelzbergstrasse 7, Zurich, Switzerland
GMP manufacture of phages for clinical trial
Tony Hitchcock, Technology Director, Cobra Biologics
Overview on Yersinia phages and update on phage therapy initiative in Finland
Professor Mikael Skurnik, Ph.D., Professor of Bacteriology, Haartman Institute, Department of Bacteriology and Immunology, Research Programs Unit, Immunobiology, Helsinki University Central Hospital Laboratory Diagnostics, Finland
Dr. Heather E. Allison, University of Liverpool, BioSciences Building, Crown Street, Liverpool, United Kingdom
Talk title to be confirmed
Dr Magdalena Plotka, Department of Microbiology, University of Gdansk, Poland, Department of Microbiology, University of Gdansk, Gdansk, Poland
Leveraging bacteriophages for high speed, enrichment-free environmental monitoring
Dr Michael Koeris, Founder, VP Business Development & Operations, Sample6, Inc, Boston, US
Atomic structure of Bordetella phage BPP1 reveals a new topology of the highly conserved HK97-like fold
Professor Z. Hong Zhou, Ph.D., Electron Imaging Center for Nanomachines (EICN), CNSI and Dept of Microbiology, Immun. & Mol. Genetics, UCLA, Los Angeles, CA, USA
Novel polymerases from marine phages
Dr Bin Zhu, Boston, MA, USA
Phage therapy in a post antibiotic era: The savior of the human race or a pie in the sky
Professor. Robert R. Bragg, Dept. of Microbial, Biochemical & Food Biotechnology, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa
Phage therapy for collibacillosis and salmonellosis for poultry production
Associate Professor. Dr. Sieo Chin Chin, Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Selangor Darul Ehsan, Malaysia
TBC
Dr Jodi A Lindsay, PhD, St George’s, University of London, London, UK
Modern ideas for combating bacteria
Dr Zuzanna Drulis-Kawa PhD., Institute of Genetics and Microbiology, University of Wroclaw, Poland
TBC
Dr Paul CM Fogg, University of York, Department of Biology, Wentworth Way, York, UK
TBC
Dr Steven Hagens, PhD, Chief Scientific Officer, The Netherlands
Crystal structures of the Fibre Proteins of Bacteriophage T4, T5 and T7
Dr Mark van Raaij, Lab 20B, Madrid, Spain
Confirmed Speakers Include
Professor Stephane Evoy, University of Alberta, Canada
Professor Louise Temple, James Madison University, Harrisonburg, Virginia, USA
